Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2022 Results Conference Call February 7, 2023 5:00 PM ET
Company Participants
Ezgi Yagci - Vice President of Investor Relations
Tim Herbert - President & Chief Executive Officer
Rick Buchholz - Chief Financial Officer
Conference Call Participants
Travis Steed - Bank of America
Robbie Marcus - JPMorgan
Adam Maeder - Piper Sandler
Rich Newitter - Truist
Larry Biegelsen - Wells Fargo
John Block - Stifel
Michael Polark - Wolfe Research
Chris Pasquale - Nephron Research
Matthew Mishan - KeyBanc
Suraj Kalia - Oppenheimer
Operator
Good afternoon. My name is Josh, and I'll be your conference operator today. At this time, I would like to welcome everyone to the Inspire Medical Systems Fourth Quarter and Full Year 2022 Conference Call. All lines have been placed in mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.
I'll now hand the conference over to your first speaker, Ezgi Yagci, the Vice President of Investor Relations at Inspire. You may begin the conference.
Ezgi Yagci
Thank you, Josh, and thank you all for participating in today's call. Joining me are Tim Herbert, President and Chief Executive Officer; and Rick Buchholz, Chief Financial Officer. Earlier today, we released financial results for the 3 and 12 months ended December 31, 2022. A copy of the press release is available on our website.
On this call management will make forward-looking statements within the meaning of the Federal Securities Laws. All forward-looking statements, including without limitation, those relating to our operations, financial results and financial condition, investments in our business, continued effects of the COVID-19 pandemic, full year 2023 financial and operational outlook, and improvements in market access are based upon our current estimates and various assumptions.
Statements involve material risks and uncertainties that could cause actual results or events to materially differ. Accordingly, you should not place undue reliance on these statements. Please see our filings with the Securities and Exchange Commission including our annual report on Form 10-K to be filed with the SEC by February 14 for a description of these risks and uncertainties.
Inspire disclaims any intention or obligation, except as required by laws to update or revise any financial projections or forward-looking statements, whether because of new information, future events or otherwise. This conference call contains time sensitive information and speaks only as of the live broadcast today, February 7, 2023.